[Pharmacotherapy: migraine and depression. Therapy with sumatripten and citalopram: perioperative anaesthesiological risk assessment].
We report on a case of a patient with migraine and depression treated with citalopram and sumatriptan. The drug evaluation is presented using the actual summaries of product characteristics (SPC, "Fachinformationen"). Particular the individual perioperative anaesthesiological risk assessment regarding the pharmacodynamic and pharmacointeractions is discussed.
Ittner
Karl Peter
KP
Klinik für Anästhesiologie, Universitätsklinikum Regensburg. karl-peter.ittner@klinik.uni-regensburg.de
D000777:Anesthetics / Q000008:administration & dosage / Q000009:adverse effects; D000928:Antidepressive Agents / Q000008:administration & dosage; D015283:Citalopram / Q000008:administration & dosage*; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications / Q000188:drug therapy*; D019990:Perioperative Care / Q000379:methods*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage; D018170:Sumatriptan / Q000008:administration & dosage*
D000777:Anesthetics; D000928:Antidepressive Agents; D004338:Drug Combinations; D017366:Serotonin Receptor Agonists; D015283:Citalopram; D018170:Sumatriptan